UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 43

Sortiert nach

Total Synthesis and Antitumor Activity of ZK-EPO: The First Fully Synthetic Epothilone in Clinical Development

Angewandte Chemie (International ed.), 2006-12, Vol.45 (47), p.7942-7948

2006

Link zum Volltext

Verfügbarkeit prüfen

A Modular Cell-Type Focused Inflammatory Process Network Model for Non-Diseased Pulmonary Tissue

Bioinformatics and Biology Insights, 2013-01, Vol.2013 (7), p.167-192

2013

Link zum Volltext

Verfügbarkeit prüfen

Systematic Verification of Upstream Regulators of a Computable Cellular Proliferation Network Model on Non-Diseased Lung Cells Using a Dedicated Dataset

Bioinformatics and Biology Insights, 2013-01, Vol.2013 (7), p.217-230

2013

Link zum Volltext

Verfügbarkeit prüfen

Improved Cellular Pharmacokinetics and Pharmacodynamics Underlie the Wide Anticancer Activity of Sagopilone

Cancer research (Chicago, Ill.), 2008-07, Vol.68 (13), p.5301-5308

2008

Link zum Volltext

Verfügbarkeit prüfen

Studies on the development of resistance to the pure antiestrogen Faslodex™ in three human breast cancer cell lines

The Journal of steroid biochemistry and molecular biology, 2003-05, Vol.85 (1), p.33-47

2003

Link zum Volltext

Verfügbarkeit prüfen

Towards the validation of a lung tumorigenesis model with mainstream cigarette smoke inhalation using the A/J mouse

Toxicology (Amsterdam), 2013-03, Vol.305, p.49-64

2013

Link zum Volltext

Verfügbarkeit prüfen

Construction of a computable cell proliferation network focused on non-diseased lung cells

BMC systems biology, 2011-07, Vol.5 (115), p.105-105, Article 105

2011

Link zum Volltext

Verfügbarkeit prüfen

Signaling-inactive epidermal growth factor receptor/ligand complexes in intact carcinoma cells by quinazoline tyrosine kinase inhibitors

Cancer research (Chicago, Ill.), 2001-08, Vol.61 (15), p.5790-5795

2001

Link zum Volltext

Verfügbarkeit prüfen

Estrogen/EGF receptor interactions in breast cancer: rationale for new therapeutic combination strategies

Biomedicine & pharmacotherapy, 2003-12, Vol.57 (10), p.447-451

Lichtner, Rosemarie B.

2003

Link zum Volltext

Verfügbarkeit prüfen

Characterization of new estrogen receptor destabilizing compounds: Effects on estrogen-sensitive and tamoxifen-resistant breast cancer

JNCI : Journal of the National Cancer Institute, 2004-02, Vol.96 (3), p.210-218

2004

Link zum Volltext

Verfügbarkeit prüfen

EGF receptor targeting in therapy-resistant human tumors

Drug resistance updates, 2002-02, Vol.5 (1), p.11-18

2002

Link zum Volltext

Verfügbarkeit prüfen

Selective increase of ?2-integrin sub-unit expression on human carcinoma cells upon EGF-receptor activation

International journal of cancer, 1999-02, Vol.80 (4), p.546-552

1999

Link zum Volltext

Verfügbarkeit prüfen

Cellular distribution and biological activity of epidermal growth factor receptors in A431 cells are influenced by cell-cell contact

Journal of cellular physiology, 1990-08, Vol.144 (2), p.303-312

1990

Link zum Volltext

Verfügbarkeit prüfen

EGF receptor in neoplasia and metastasis

Cancer and metastasis reviews, 1993-09, Vol.12 (3-4), p.255-274

1993

Link zum Volltext

Verfügbarkeit prüfen

Estrogen/EGF receptor interactions in breast cancer: rationale for new therapeutic combination strategies : Breast cancers

Biomedicine & pharmacotherapy, 2003, Vol.57 (10), p.447-451

LICHTNER, Rosemarie B

2003

Link zum Volltext

Verfügbarkeit prüfen

Cover Picture: Total Synthesis and Antitumor Activity of ZK-EPO: The First Fully Synthetic Epothilone in Clinical Development (Angew. Chem. Int. Ed. 47/2006)

Angewandte Chemie (International ed.), 2006-12, Vol.45 (47), p.7855-7855

2006

Link zum Volltext

Verfügbarkeit prüfen

Systematic Verification of Upstream Regulators of a Computable Cellular Proliferation Network Model on Non-Diseased Lung Cells Using a Dedicated Dataset

Bioinformatics and biology insights, 2013-07, Vol.2013 (7), p.217-230

2013

Link zum Volltext

Verfügbarkeit prüfen

Total Synthesis and Antitumor Activity of ZK‐EPO: The First Fully Synthetic Epothilone in Clinical Development

Angewandte Chemie, 2006-12, Vol.118 (47), p.8110-8116

2006

Link zum Volltext

Verfügbarkeit prüfen

Titelbild: Total Synthesis and Antitumor Activity of ZK‐EPO: The First Fully Synthetic Epothilone in Clinical Development (Angew. Chem. 47/2006)

Angewandte Chemie, 2006-12, Vol.118 (47), p.8019-8019

2006

Link zum Volltext

Verfügbarkeit prüfen

A Modular Cell-Type Focused Inflammatory Process Network Model for Non-Diseased Pulmonary Tissue

Bioinformatics and biology insights, 2013-06, Vol.2013 (7), p.167-192

2013

Link zum Volltext

Verfügbarkeit prüfen

Construction of a Computable Network Model for DNA Damage, Autophagy, Cell Death, and Senescence

Bioinformatics and biology insights, 2013-03, Vol.2013 (7), p.97-117

2013

Link zum Volltext

Verfügbarkeit prüfen

A link between ras and metastatic behavior of tumor cells : ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells

Cancer research (Chicago, Ill.), 1993-04, Vol.53 (7), p.1516-1521

1993

Link zum Volltext

Verfügbarkeit prüfen

Selective increase of α2‐integrin sub‐unit expression on human carcinoma cells upon EGF‐receptor activation

International journal of cancer, 1999-02, Vol.80 (4), p.546-552

1999

Link zum Volltext

Verfügbarkeit prüfen

Negative Cooperativity between α3β1and α2β1Integrins in Human Mammary Carcinoma MDA MB 231 Cells

Experimental cell research, 1998-05, Vol.240 (2), p.368-376

1998

Link zum Volltext

Verfügbarkeit prüfen

Ligand mediated activation of ectopic EGF receptor promotes matrix protein adhesion and lung colonization of rat mammary adenocarcinoma cells

Oncogene, 1995-05, Vol.10 (9), p.1823-1832

1995

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(43)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(25)
Life Sciences & Biomedicine
(24)
Animals
(19)
Oncology
(14)
Biological And Medical Sciences
(13)
Humans
(13)
Rats
(11)
Medical Sciences
(10)
Female
(9)
Tumor Cells, Cultured
(8)
Receptor, Epidermal Growth Factor - Physiology
(7)
Antineoplastic Agents
(6)
Cell Biology
(6)
Mammary Neoplasms, Experimental - Pathology
(6)
Mice
(6)
Pharmacology. Drug Treatments
(6)
Biochemistry & Molecular Biology
(5)
Breast Neoplasms - Drug Therapy
(5)
Epidermal Growth Factor - Pharmacology
(5)
Tumors
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Total Synthesis and Antitumor Activity of ZK-EPO: The First Fully Synthetic Epothilone in Clinical Development

A Modular Cell-Type Focused Inflammatory Process Network Model for Non-Diseased Pulmonary Tissue

Systematic Verification of Upstream Regulators of a Computable Cellular Proliferation Network Model on Non-Diseased Lung Cells Using a Dedicated Dataset

Improved Cellular Pharmacokinetics and Pharmacodynamics Underlie the Wide Anticancer Activity of Sagopilone

Studies on the development of resistance to the pure antiestrogen Faslodex™ in three human breast cancer cell lines

Towards the validation of a lung tumorigenesis model with mainstream cigarette smoke inhalation using the A/J mouse

Construction of a computable cell proliferation network focused on non-diseased lung cells

Signaling-inactive epidermal growth factor receptor/ligand complexes in intact carcinoma cells by quinazoline tyrosine kinase inhibitors

Estrogen/EGF receptor interactions in breast cancer: rationale for new therapeutic combination strategies

Characterization of new estrogen receptor destabilizing compounds: Effects on estrogen-sensitive and tamoxifen-resistant breast cancer

EGF receptor targeting in therapy-resistant human tumors

Selective increase of ?2-integrin sub-unit expression on human carcinoma cells upon EGF-receptor activation

Cellular distribution and biological activity of epidermal growth factor receptors in A431 cells are influenced by cell-cell contact

EGF receptor in neoplasia and metastasis

Estrogen/EGF receptor interactions in breast cancer: rationale for new therapeutic combination strategies : Breast cancers

Cover Picture: Total Synthesis and Antitumor Activity of ZK-EPO: The First Fully Synthetic Epothilone in Clinical Development (Angew. Chem. Int. Ed. 47/2006)

Systematic Verification of Upstream Regulators of a Computable Cellular Proliferation Network Model on Non-Diseased Lung Cells Using a Dedicated Dataset

Total Synthesis and Antitumor Activity of ZK‐EPO: The First Fully Synthetic Epothilone in Clinical Development

Titelbild: Total Synthesis and Antitumor Activity of ZK‐EPO: The First Fully Synthetic Epothilone in Clinical Development (Angew. Chem. 47/2006)

A Modular Cell-Type Focused Inflammatory Process Network Model for Non-Diseased Pulmonary Tissue

Construction of a Computable Network Model for DNA Damage, Autophagy, Cell Death, and Senescence

A link between ras and metastatic behavior of tumor cells : ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells

Selective increase of α2‐integrin sub‐unit expression on human carcinoma cells upon EGF‐receptor activation

Negative Cooperativity between α3β1and α2β1Integrins in Human Mammary Carcinoma MDA MB 231 Cells

Ligand mediated activation of ectopic EGF receptor promotes matrix protein adhesion and lung colonization of rat mammary adenocarcinoma cells

Suchergebnisse filtern